At4g39110 Antibody

What is AT4G39110 (BUPS1) and why is it important in plant research?

AT4G39110, also known as BUPS1, is a member of the CrRLK1L family of receptor-like kinases in plants. This protein is particularly important in plant reproduction research as it is highly expressed in pollen and plays a role in pollen tube growth and fertilization processes . Research has shown that BUPS1 interacts with other proteins such as CAR9, making it a significant component in cell signaling pathways . Understanding BUPS1 function contributes to broader knowledge of plant reproduction and cell-cell communication mechanisms.

What sample types are suitable for AT4G39110 antibody applications?

AT4G39110 antibodies can be used with various Arabidopsis tissue samples, with pollen samples being particularly relevant due to the high expression of this protein in pollen . For optimal results, mature pollen grains can be isolated from Arabidopsis flowers and processed according to standard protocols for protein extraction. Additionally, researchers can use plant cell cultures or transgenic plant lines expressing tagged versions of AT4G39110 for specific applications. When working with plant tissues, it's crucial to include appropriate controls to validate antibody specificity .

How should AT4G39110 antibodies be validated before experimental use?

Validation of AT4G39110 antibodies should include:

• Western blot analysis using recombinant AT4G39110 protein or extracts from tissues known to express the protein (particularly pollen)

• Negative controls using tissues from knockout mutants of AT4G39110 (like the T-DNA insertion lines mentioned in search result )

• Immunoprecipitation followed by mass spectrometry to confirm target specificity

• Cross-reactivity testing with closely related proteins such as AT2G21480 (BUPS2), which shares conserved peptides with AT4G39110

• Antibody titration to determine optimal working concentration and reduce background staining

What protein extraction methods are recommended for AT4G39110 detection in pollen samples?

For effective extraction of AT4G39110 from pollen samples:

• Collect mature pollen grains from Arabidopsis flowers

• Use a buffer containing phosphatase inhibitors to preserve phosphorylation states, as AT4G39110 is a phosphoprotein present in the mature Arabidopsis pollen phosphoproteome

• Include protease inhibitors to prevent protein degradation

• Consider using mild detergents (0.1-0.5% NP-40 or Triton X-100) to solubilize membrane-associated proteins

• Sonication or mechanical disruption methods may be necessary due to the robust nature of pollen cell walls

• Clarify extracts by centrifugation before immunoprecipitation or western blot analysis

This approach will help preserve both the protein integrity and post-translational modifications that are important for studying AT4G39110 function.

How can phosphorylation states of AT4G39110 be preserved and detected in antibody-based experiments?

AT4G39110 has been identified as part of the phosphoproteome in mature Arabidopsis pollen , making preservation of its phosphorylation state critical for comprehensive functional studies. To preserve and detect phosphorylation:

• Use extraction buffers containing multiple phosphatase inhibitors (sodium fluoride, sodium orthovanadate, and β-glycerophosphate)

• Maintain samples at 4°C throughout processing

• Consider using phospho-specific antibodies if particular phosphorylation sites of AT4G39110 are of interest

• After immunoprecipitation with AT4G39110 antibodies, analyze samples with:

  • Phospho-specific western blotting

  • Mass spectrometry for precise mapping of phosphorylation sites

  • Phos-tag SDS-PAGE to separate phosphorylated from non-phosphorylated forms

The analysis of AT4G39110 phosphorylation can provide insights into how this protein's activity is regulated during pollen development and pollen tube growth.

What are the best approaches for studying AT4G39110 protein-protein interactions using antibodies?

For studying AT4G39110 protein-protein interactions:

• Co-immunoprecipitation (Co-IP): Use validated AT4G39110 antibodies to pull down the protein complex from pollen extracts, followed by mass spectrometry or western blotting to identify interacting partners. Research has shown that AT4G39110 (BUPS1) interacts with CAR family proteins .

• Proximity-based labeling: Consider using BioID or APEX2 fused to AT4G39110 to identify proteins in close proximity in vivo.

• Förster Resonance Energy Transfer (FRET): Use fluorescently labeled antibodies or fusion proteins to detect direct interactions in vivo.

• Yeast Two-Hybrid validation: Complement antibody-based methods with Y2H assays, as demonstrated in studies showing that CAR9 interacted specifically with FER and BUPS1, but not with other tested kinase domains .

• Split-fluorescent protein complementation: Express fragments of fluorescent proteins fused to AT4G39110 and potential interactors to visualize interactions in planta.

When designing these experiments, it's crucial to include appropriate controls and consider the membrane localization of AT4G39110.

How can AT4G39110 antibodies be used to investigate its role in cell wall integrity signaling pathways?

AT4G39110 (BUPS1) is implicated in cell wall integrity signaling as part of the CrRLK1L family. To investigate its specific role:

• Immunolocalization studies: Use AT4G39110 antibodies in combination with markers for membrane nanodomains to study co-localization. This approach can reveal if AT4G39110 associates with specific membrane regions, similar to how FER associates with ordered lipid domains in the plasma membrane .

• Comparative studies: Compare AT4G39110 localization in wild-type plants versus mutants with cell wall defects or under treatments that affect cell wall integrity (like enzymatic degradation).

• Differential extraction: Use sequential extractions with increasing detergent strengths to determine the association strength of AT4G39110 with membrane fractions before and after cell wall stress.

• Functional assays: Combine antibody detection with cell wall integrity assays (such as monitoring reactive oxygen species production or calcium influx) to correlate AT4G39110 levels or localization with cellular responses.

• Super-resolution microscopy: Use fluorescently labeled AT4G39110 antibodies with techniques like STORM or PALM to visualize nanoscale localization patterns at the cell surface.

These approaches can help elucidate how AT4G39110 contributes to sensing and responding to cell wall status in pollen tubes.

What strategies exist for multiplexing AT4G39110 antibodies with other markers in complex plant reproductive tissue analyses?

For multiplexed detection of AT4G39110 with other proteins in reproductive tissues:

When developing these protocols, fluorescence minus one (FMO) controls are essential to accurately set gates and quantify expression in multiplexed settings .

How can sequence conservation between AT4G39110 and related proteins impact antibody specificity?

The high sequence conservation between AT4G39110 (BUPS1) and related proteins poses significant challenges for antibody specificity:

• Sequence analysis shows that AT4G39110 shares conserved peptides with AT2G21480 (BUPS2), making cross-reactivity a potential issue .

• When designing or selecting antibodies:

  • Target unique regions that differ from other CrRLK1L family members

  • Avoid the cytoplasmic domain regions that show high conservation among family members

  • Consider using peptide competition assays to confirm specificity

  • Validate antibodies in tissues from knockout mutants of AT4G39110

• For critical experiments, consider using epitope-tagged versions of AT4G39110 expressed under native promoters in knockout backgrounds, allowing the use of highly specific tag antibodies.

• When interpreting results, always consider the possibility of detecting closely related family members and include appropriate controls.

The table below shows the similarity between AT4G39110 and selected related CrRLK1L family members:

What fixation and permeabilization protocols are recommended for AT4G39110 immunolocalization in pollen?

For successful immunolocalization of AT4G39110 in pollen:

• Fixation options:

  • 4% paraformaldehyde (PFA) for 30-60 minutes preserves protein structure while allowing antibody access

  • For phosphoprotein preservation, include phosphatase inhibitors in the fixative

  • Avoid methanol fixation which can disrupt membrane proteins

• Permeabilization considerations:

  • Pollen has a robust cell wall requiring more aggressive permeabilization

  • Use 0.1-0.5% Triton X-100 or NP-40 for membrane permeabilization

  • For accessing intracellular epitopes, consider enzymatic cell wall digestion with a cocktail of cellulase and pectinase prior to detergent permeabilization

  • Brief treatment with low concentrations of saponin can help preserve membrane structure while allowing antibody access

• Blocking:

  • Use 3-5% BSA or normal serum from the same species as the secondary antibody

  • Include 0.1% Tween-20 to reduce non-specific binding

  • Consider adding 10% normal serum from the species of the tissue to reduce non-specific binding

• Special considerations for pollen tubes:

  • For growing pollen tubes, perform rapid fixation to capture dynamic processes

  • Consider live-cell imaging with fluorescently tagged proteins as a complementary approach

These protocols may require optimization depending on the specific epitope recognized by the AT4G39110 antibody.

How can researchers troubleshoot non-specific binding when using AT4G39110 antibodies?

When encountering non-specific binding with AT4G39110 antibodies:

• Antibody validation:

  • Test antibodies on samples from AT4G39110 knockout lines as negative controls

  • Use peptide blocking to confirm specificity to the immunizing peptide

  • Consider testing multiple antibodies targeting different epitopes

• Protocol optimization:

  • Increase blocking agent concentration (5-10% BSA or normal serum)

  • Extend blocking time to 1-2 hours at room temperature or overnight at 4°C

  • Add 0.1-0.2% Tween-20 to reduce hydrophobic interactions

  • Include 5-10mM glycine to block free aldehyde groups after fixation

  • Test different detergent concentrations for permeabilization

• Address plant-specific challenges:

  • Include plant-derived blocking agents like non-fat milk powder

  • Pre-absorb antibodies with plant tissue powder from knockout lines

  • Use Fc receptor blocking reagents if available

• Signal-to-noise enhancement:

  • Optimize antibody concentration through proper titration

  • Use indirect detection with highly cross-adsorbed secondary antibodies

  • Try tyramide signal amplification for weak signals

  • Employ viability dyes to exclude dead cells which bind antibodies non-specifically

What considerations should be made when designing experiments to study AT4G39110 phosphorylation states?

When studying AT4G39110 phosphorylation:

• Phosphorylation site mapping:

  • AT4G39110 is part of the pollen phosphoproteome with potentially multiple phosphorylation sites

  • Consider using phospho-specific antibodies for key regulatory sites

  • For comprehensive mapping, use immunoprecipitation followed by mass spectrometry

• Experimental design:

  • Include phosphatase inhibitors (sodium fluoride, sodium orthovanadate, β-glycerophosphate) in all buffers

  • Compare phosphorylation states under different conditions (e.g., before and after pollen germination)

  • Use λ-phosphatase treatment as a negative control

  • Consider using Phos-tag gels to separate phosphorylated from non-phosphorylated forms

• Functional correlation:

  • Correlate phosphorylation states with protein-protein interactions

  • Investigate how phosphorylation affects localization using immunofluorescence

  • Study the impact of kinase or phosphatase inhibitors on AT4G39110 function

• Quantification methods:

  • Use quantitative western blotting with phospho-specific antibodies

  • Consider ELISA-based approaches for high-throughput analysis

  • For spatial information, use phospho-specific antibodies in immunolocalization studies

How can AT4G39110 antibodies contribute to understanding RALF signaling pathways in pollen tube growth?

AT4G39110 (BUPS1) is implicated in RALF signaling pathways, which are important for cell wall integrity during pollen tube growth . Antibodies against AT4G39110 can contribute to this research area through:

• Receptor complex visualization:

  • Use co-immunoprecipitation with AT4G39110 antibodies to isolate receptor complexes containing RALF peptides

  • Perform immunofluorescence to visualize co-localization of AT4G39110 with RALF peptides, LLG proteins, or other CrRLK1L family members

  • Study the formation and dynamics of receptor complexes in response to RALF treatment

• Signaling pathway dissection:

  • Track AT4G39110 phosphorylation states in response to RALF peptide application

  • Analyze protein complex formation in wild-type versus mutant backgrounds

  • Investigate how disruption of AT4G39110 affects downstream RALF signaling events

• Functional studies:

  • Compare AT4G39110 localization and abundance in normal versus compromised pollen tube growth

  • Perform antibody inhibition studies to block protein function in pollen tube growth assays

  • Correlate AT4G39110 expression with phenotypic changes in RALF-regulated processes

• Comparative studies:

  • Use antibodies to compare AT4G39110 expression and localization patterns across plant species

  • Investigate conservation of RALF-CrRLK1L signaling mechanisms between Arabidopsis and other plants such as maize

This research direction could yield important insights into the molecular mechanisms governing pollen tube growth and fertilization.

What opportunities exist for using AT4G39110 antibodies in conjunction with deep learning-based protein structure analysis?

The emerging field of deep learning for protein structure prediction and analysis offers new opportunities for AT4G39110 research:

• Epitope validation and refinement:

  • Use structural prediction tools like those mentioned in reference to identify accessible epitopes for new antibody development

  • Validate existing antibody epitopes against predicted protein structures

  • Design structure-guided antibodies targeting specific functional domains

• Structure-function correlations:

  • Combine experimental data from antibody studies with structural predictions to understand protein interactions

  • Use antibodies to validate computationally predicted conformational changes

  • Target antibodies to regions predicted to undergo structural changes during signaling

• Integration with diffusion probabilistic models:

  • Apply deep generative models similar to those used in antibody design to predict AT4G39110 structural variants

  • Use antibodies to validate predictions made by these models

  • Develop custom antibodies against predicted binding interfaces

• Multiscale modeling:

  • Integrate antibody-derived experimental data with computational models of protein-protein interactions

  • Use immunoprecipitation data to refine interaction models

  • Develop feedback loops between experimental and computational approaches

These approaches represent the cutting edge of structural biology and could significantly advance our understanding of AT4G39110 function.

How can AT4G39110 antibodies be used in chromatin immunoprecipitation experiments to study potential DNA interactions?

While AT4G39110 is primarily a receptor-like kinase, investigating potential nuclear roles or interactions with transcription factors could be valuable:

• ChIP protocol adaptations:

  • Use dual crosslinking with DSG followed by formaldehyde to capture protein-protein interactions before DNA binding

  • Include appropriate controls such as IgG antibodies and input samples

  • Validate ChIP-grade quality of AT4G39110 antibodies

• Analysis approaches:

  • Perform ChIP-seq to identify genome-wide binding patterns

  • Use ChIP-qPCR to validate binding to specific genomic regions

  • Consider sequential ChIP (Re-ChIP) to identify co-occupancy with transcription factors

• Challenges and considerations:

  • AT4G39110 is not primarily a DNA-binding protein, so indirect interactions would be more likely

  • Focus on potential signaling-to-transcription pathways

  • Compare results with ChIP data from known transcription factors in the same pathway

What are the current limitations of AT4G39110 antibody applications and how might they be addressed?

Current limitations and potential solutions for AT4G39110 antibody applications include:

• Specificity challenges:

  • High sequence similarity with other CrRLK1L family members, particularly AT2G21480 (BUPS2)

  • Solution: Develop antibodies against unique regions or use epitope-tagged versions in knockout backgrounds

• Post-translational modifications:

  • AT4G39110 undergoes phosphorylation in mature pollen , which may affect antibody recognition

  • Solution: Develop modification-specific antibodies or use techniques that preserve these modifications

• Accessibility in plant tissues:

  • Plant cell walls and hydrophobic cuticles can limit antibody penetration

  • Solution: Optimize permeabilization protocols specifically for pollen and develop clearing techniques compatible with immunostaining

• Quantification challenges:

  • Plant autofluorescence can interfere with immunofluorescence quantification

  • Solution: Use appropriate spectral unmixing, alternative detection methods, or fluorophores outside the autofluorescence spectrum

• Limited commercial availability:

  • Specialized plant protein antibodies often have limited availability

  • Solution: Establish repositories for validated plant antibodies and standardized validation protocols

Future technological developments like nanobodies or aptamers may address some of these limitations by offering smaller probes with potentially better tissue penetration and specificity.